Cartesian Therapeutics
Develops outpatient mRNA CAR-T candidates for autoimmune diseases, led by Descartes-08.
$9.60
After-hours close+0.03 (+0.31%)
At close$9.57(−4.01%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.02 | — | — |
| Aug 2026 | −$0.88 | $0.46 | +152.4% |
| Apr 2026 | −$0.84 | −$1.46 | −73.8% |
| Mar 2026 | −$0.82 | −$1.38 | −68.3% |
| Nov 2025 | −$0.81 | −$1.38 | −70.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$1.02 | — | — | $150.0K | — | — |
| Aug 6, 2026 | −$0.88 | $0.46 | +152.4% | $179.7K | $164.0K | −8.7% |
| Apr 30, 2026 | −$0.84 | −$1.46 | −73.8% | $219.8K | $78.0K | −64.5% |
| Mar 9, 2026 | −$0.82 | −$1.38 | −68.3% | $150.3K | $947.0K | +529.9% |
| Nov 6, 2025 | −$0.81 | −$1.38 | −70.4% | $100.2K | $452.0K | +351.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 17, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Dec 30, 2022 | ||||||
| Sep 29, 2022 | ||||||
| Jun 29, 2022 | ||||||
| Mar 30, 2022 | ||||||
| Dec 30, 2021 | ||||||
| Sep 29, 2021 | ||||||
| Jun 29, 2021 | ||||||
| Mar 30, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Sep 30, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||
| Dec 31, 2017 | ||||||
| Sep 30, 2017 | ||||||
| Jun 30, 2017 | ||||||
| Mar 31, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||
| Dec 30, 2015 | ||||||
| Sep 30, 2015 | ||||||
| Jun 30, 2015 | ||||||